吸入式一氧化氮市场：按产品类型、按应用、按强度、按最终用户、按地区

2025 年全球吸入式一氧化氮市场规模估计为 13.1 亿美元，预计 2032 年将达到 22.1 亿美元，2025 年至 2032 年的年复合成长率为 7.7%。

数字。 2025年吸入式一氧化氮市场占有率（按地区）

吸入性一氧化氮（iNO）是一种选择性肺血管扩张剂，核准用于治疗患有低氧血症性呼吸衰竭的新生儿和足月新生儿。 iNO透过扩张肺血管、改善通气-灌注匹配和降低肺动脉高压发挥作用。吸入时，iNO 会与肺部的氧气和水迅速反应生成二氧化氮和硝酸盐。由于这些分解产物不溶于脂，因此很少iNO进入血液，不会造成全身血管扩张。透过这种选择性肺血管扩张，iNO 能够显着改善患有低氧血症性呼吸衰竭的新生儿的氧合，而不会加剧通气灌注不匹配或引起全身性低血压。

市场动态：

全球吸入性一氧化氮市场的成长是由早产和新生儿呼吸窘迫症候群发病率的上升所推动的。例如，根据世界卫生组织（WHO）2025年5月报告的数据，早产是五岁以下儿童死亡的主要原因。早产併发症将导致2020年约90万名儿童死亡，其中75%可透过具成本效益的介入措施来预防。此外，吸入一氧化氮越来越多地被主要临床实践指南推荐作为新生儿低氧性呼吸衰竭的一线治疗方法，加速了其应用。然而，iNO输送系统和气瓶的价格过高可能会抑制市场成长。同时，正在进行的关于 iNO 对成人急性呼吸窘迫症候群(ARDS) 等其他肺部疾病的有效性的研究为市场扩张提供了有利可图的机会。

本研究的主要特点

本报告对全球吸入式一氧化氮市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。

它强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，对全球吸入式一氧化氮市场的主要企业进行了概述。

研究中介绍的主要企业包括 Mallinckrodt plc、Linde PLC、Nippon Oxygen Holdings、SOL Group、Air Liquide SA、Air Water Inc.、Chemix Specialty Gases and Equipment、Vero Biotech LLC、四川萨尔曼化学产品有限公司、成都泰宇工业有限公司、Bellerophon Therapeutics Inc.、MJA.Fellernx. Plus Inc.、Beyond Air Inc.、Praxair Technology Inc.、Getinge Group 和 Circassia Pharmaceuticals。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员将透过用于分析全球吸入式一氧化氮市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 司机
• 限制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 吸入式一氧化氮市场（依产品类型），2020 年至 2032 年

• 吸入式一氧化氮输送系统
• 耗材
• 一氧化氮气瓶
• 运输配件
• 其他的

5. 吸入式一氧化氮市场（依应用划分），2020 年至 2032 年

• 新生儿呼吸护理
• 慢性阻塞性肺病（COPD）
• 急性呼吸窘迫症候群（ARDS）
• 结核病治疗
• 疟疾治疗
• 其他的

6. 吸入式一氧化氮市场（按强度），2020 年至 2032 年

• 100ppm
• 800ppm
• 其他的

7. 吸入式一氧化氮市场（以最终用户划分），2020 年至 2032 年

• 医院
• 门诊手术中心
• 居家照护环境

8. 吸入式一氧化氮市场（依地区划分），2020 年至 2032 年

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争态势

• Mallinckrodt plc
• Linde PLC
• Nippon Sanso Holdings Corporation
• SOL Group
• Air Liquide SA
• Air Water Inc.
• Chemix Specialty Gases and Equipment
• Vero Biotech LLC
• Sichuan Salman Chemical Products Co., Ltd.
• Chengdu Taiyu Industrial Gases Co., Ltd.
• Bellerophon Therapeutics Inc.
• Merck KGaA
• GE Healthcare
• Mitsubishi Tanabe Pharma Corporation
• Messer Group
• Nu-Med Plus Inc.
• Beyond Air Inc.
• Praxair Technology Inc.
• Getinge Group
• Circassia Pharmaceuticals

第 10 章分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第 11 章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Inhaled Nitric Oxide Market is estimated to be valued at USD 1.31 Bn in 2025 and is expected to reach USD 2.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Figure. Inhaled Nitric Oxide Market Share (%), By Region 2025

Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator approved for treating term and near-term neonates with hypoxic respiratory failure. iNO works by dilating pulmonary vessels, improving ventilation-perfusion matching, and reducing pulmonary hypertension. Upon inhalation, iNO rapidly reacts with oxygen and water in the lungs to produce nitrogen dioxide and nitrate. As these breakdown products are not lipid soluble, iNO has very little ability to enter the bloodstream and cause systemic vasodilation. This selective pulmonary vasodilation allows iNO to significantly improve oxygenation without worsening ventilation/perfusion mismatching or causing systemic hypotension in neonates with hypoxic respiratory failure.

Market Dynamics:

The global inhaled nitric oxide market growth is driven by the rising incidence of preterm births and respiratory distress syndrome among neonates. For Instance, in May 2025, according to the data reported by World Health Organization, prematurity is the leading cause of death among children under 5 years of age. Preterm birth complications caused around 900,000 child deaths in 2020, with 75% preventable through cost-effective interventions; global preterm birth rates in 2020 ranged from 4-16%. Moreover, inhaled nitric oxide has been increasingly recommended as the first-line therapy for hypoxic respiratory failure in newborns by leading clinical practice guidelines, thereby fuelling its adoption. However, the market growth can be restrained by the exorbitant price of iNO delivery systems and cylinders. On the other hand, ongoing research on the efficacy of iNO in other lung conditions like acute respiratory distress syndrome (ARDS) in adults presents lucrative opportunities for market expansion.

Key features of the study:

This report provides in-depth analysis of the global inhaled nitric oxide market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global inhaled nitric oxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Mallinckrodt plc, Linde PLC, Nippon Sanso Holdings Corporation, SOL Group, Air Liquide S.A., Air Water Inc., Chemix Specialty Gases and Equipment, Vero Biotech LLC, Sichuan Salman Chemical Products Co., Ltd., Chengdu Taiyu Industrial Gases Co., Ltd., Bellerophon Therapeutics Inc., Merck KGaA, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Messer Group, Nu-Med Plus Inc., Beyond Air Inc., Praxair Technology Inc., Getinge Group, and Circassia Pharmaceuticals.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global inhaled nitric oxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled nitric oxide market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Inhaled Nitric Oxide Delivery Systems
  • Consumables
  • Nitric Oxide Cylinders
  • Delivery Accessories
  • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Neonatal Respiratory Treatment
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Respiratory Distress Syndrome (ARDS)
  • Tuberculosis Treatment
  • Malaria Treatment
  • Others
• Strength Insights (Revenue, USD Bn, 2020 - 2032)
  • 100 ppm
  • 800 ppm
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Mallinckrodt plc
  • Linde PLC
  • Nippon Sanso Holdings Corporation
  • SOL Group
  • Air Liquide S.A.
  • Air Water Inc.
  • Chemix Specialty Gases and Equipment
  • Vero Biotech LLC
  • Sichuan Salman Chemical Products Co., Ltd.
  • Chengdu Taiyu Industrial Gases Co., Ltd.
  • Bellerophon Therapeutics Inc.
  • Merck KGaA
  • GE Healthcare
  • Mitsubishi Tanabe Pharma Corporation
  • Messer Group
  • Nu-Med Plus Inc.
  • Beyond Air Inc.
  • Praxair Technology Inc.
  • Getinge Group
  • Circassia Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Inhaled Nitric Oxide Market, By Product Type
  • Inhaled Nitric Oxide Market, By Application
  • Inhaled Nitric Oxide Market, By Strength
  • Inhaled Nitric Oxide Market, By End User
  • Inhaled Nitric Oxide Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Inhaled Nitric Oxide Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Inhaled Nitric Oxide Delivery Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nitric Oxide Cylinders
• Delivery Accessories
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Inhaled Nitric Oxide Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Neonatal Respiratory Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Obstructive Pulmonary Disease (COPD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Acute Respiratory Distress Syndrome (ARDS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tuberculosis Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Malaria Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Inhaled Nitric Oxide Market, By Strength, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 100 ppm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 800 ppm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Inhaled Nitric Oxide Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Inhaled Nitric Oxide Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Mallinckrodt plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Linde PLC
• Nippon Sanso Holdings Corporation
• SOL Group
• Air Liquide S.A.
• Air Water Inc.
• Chemix Specialty Gases and Equipment
• Vero Biotech LLC
• Sichuan Salman Chemical Products Co., Ltd.
• Chengdu Taiyu Industrial Gases Co., Ltd.
• Bellerophon Therapeutics Inc.
• Merck KGaA
• GE Healthcare
• Mitsubishi Tanabe Pharma Corporation
• Messer Group
• Nu-Med Plus Inc.
• Beyond Air Inc.
• Praxair Technology Inc.
• Getinge Group
• Circassia Pharmaceuticals

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us